| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/14/2004 | WO2004087865A2 The preparation and application of ligand-biopolymer conjugates |
| 10/14/2004 | WO2004087863A2 Non-invasive prenatal genetic diagnosis using transcervical cells |
| 10/14/2004 | WO2004087751A1 Dystrophin-related protein (drop1), a marker for carcinomas |
| 10/14/2004 | WO2004087746A2 Staphylococcus epidermidis antigens |
| 10/14/2004 | WO2004087730A2 Method for producing diverse libraries of encoded polymers |
| 10/14/2004 | WO2004087281A2 Implementation of microfluidic components, including molecular fractionation devices, in a microfluidic system |
| 10/14/2004 | WO2004087076A2 Methods for inhibiting adipogenesis and for treating type 2 diabetes |
| 10/14/2004 | WO2004087070A2 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-FUNGAL AGENTS |
| 10/14/2004 | WO2004087069A2 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-PROLIFERATIVE AGENTS |
| 10/14/2004 | WO2004087062A2 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| 10/14/2004 | WO2004087046A2 TREATMENT OR PREVENTION OF cGMP-DEPENDENT PATHOPHYSIOLOGY WITH A MUTANT VARIANT OF SOLUBLE GUANYLYL CYCLASE |
| 10/14/2004 | WO2004087044A2 Drug target |
| 10/14/2004 | WO2004086949A2 Dna markers for management of cancer |
| 10/14/2004 | WO2004086941A2 System and method for rapidly identifying pathogens, bacteria and abnormal cells |
| 10/14/2004 | WO2004072253A9 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 10/14/2004 | WO2004072232A9 Covalent tethering of functional groups to proteins |
| 10/14/2004 | WO2004063394A3 Uses of substances binding to fabp4 for diagnosing and treating bladder carcinoma |
| 10/14/2004 | WO2004061409A3 Parallel inducible cell-based kinase screen |
| 10/14/2004 | WO2004058948A3 In vivo methods for validating the role of a tumor maintenance gene |
| 10/14/2004 | WO2004048593A3 Methods for using riboprimers for strand displacement replication of target sequences |
| 10/14/2004 | WO2004048567A3 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 10/14/2004 | WO2004047623A3 Methods for identifying risk of breast cancer and treatments thereof |
| 10/14/2004 | WO2004045376A3 Screening methods to identify treatments for autoimmune disease |
| 10/14/2004 | WO2004044229A3 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) |
| 10/14/2004 | WO2004043988A3 Ptprk immunogenic peptide |
| 10/14/2004 | WO2004042402A3 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 10/14/2004 | WO2004042076A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) |
| 10/14/2004 | WO2004039311A3 Human vps4a and vps4b functions in viral budding |
| 10/14/2004 | WO2004035803A3 Method and nucleic acids for the treatment of breast cell proliferative disorders |
| 10/14/2004 | WO2004031775A3 Method for treating or preventing metastasis of colorectal cancers |
| 10/14/2004 | WO2004031774A3 Method for treating or preventing metastasis of colorectal cancers |
| 10/14/2004 | WO2004031233A3 Novel chemokine-like polypeptides |
| 10/14/2004 | WO2004029196A3 Methods of determining the effect of an agent on diploid cells and/or on the pattern of expression of polypeptides expressed therewith |
| 10/14/2004 | WO2004028341A3 Susceptibility gene for human stroke; methods of treatment |
| 10/14/2004 | WO2004025244A3 Protein arrays and uses thereof |
| 10/14/2004 | WO2004024875A8 Mammalian megakaryocyte progenitor cell |
| 10/14/2004 | WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor |
| 10/14/2004 | WO2004021010A3 Method of diagnosing colon and gastric cancers |
| 10/14/2004 | WO2004018504A3 Immune markers used for diagnosis and therapy in connection with transplant reactions |
| 10/14/2004 | WO2004011602B1 Detection of bacterial kidney disease |
| 10/14/2004 | WO2004008105A3 Detection of ligand/antiligand complex formation by electromagnetically detectable bulk property measurement |
| 10/14/2004 | WO2004006854A3 Method for identification of biologically active agents |
| 10/14/2004 | WO2003106641A3 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid |
| 10/14/2004 | WO2003104811A3 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases |
| 10/14/2004 | WO2003100092A3 Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases |
| 10/14/2004 | WO2003095666A3 Oligonucleotide probes for in vitro, in vivo and intracellular detection |
| 10/14/2004 | WO2003089620A3 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/14/2004 | WO2003088090A3 System and method for data analysis, manipulation, and visualization |
| 10/14/2004 | WO2003072700A3 Androgen receptor overexpressing skeletal myoblasts |
| 10/14/2004 | WO2003072065A3 Drug signatures |
| 10/14/2004 | WO2003035841A3 Methods and systems for dynamic gene expression profiling |
| 10/14/2004 | WO2002055664A3 Modulating insulin receptor signaling |
| 10/14/2004 | WO2002030980A8 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 10/14/2004 | WO2001075067A8 Novel nucleic acids and polypeptides |
| 10/14/2004 | US20040205835 Jak kinases and regulation of cytokine signal transduction |
| 10/14/2004 | US20040204574 TSA305 gene |
| 10/14/2004 | US20040204388 incubating SV2 protein or fragment with levetiracetam or an analog or derivative thereof and a potential binding partner and determining if the potential binding partner modulates the binding of levetiracetam to the SV2 protein |
| 10/14/2004 | US20040204361 Kdel receptor inhibitors |
| 10/14/2004 | US20040204350 Disease- associated protein |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | US20040204338 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action |
| 10/14/2004 | US20040203157 Transfroming arabidopsis with expression vector coding genes associated with heat, freeze, salt and drought resistance; using ribonucleoproteins to control effivient gene transcription in plants; bioreactors |
| 10/14/2004 | US20040203153 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made |
| 10/14/2004 | US20040203137 requires no wash steps and thus generates no liquid waste; can be readily adapted to antigen-antibody interactions over a wide kinetic range; solid phase synthesis |
| 10/14/2004 | US20040203128 Use of PP2A phosphatase modulators in the treatment of mental disorders |
| 10/14/2004 | US20040203125 recombinant chimera produced using solid phase synthesis; for biosnesors/bioreactors, diagnostic and drugs |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203114 DNA in the presence of gellan |
| 10/14/2004 | US20040203111 UDP-N-acetylglucosamine: galactose-B1,3-N-acetylgalactosamine-a-R/ (GlcNAc to GalNAc) B1-6 N- acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203105 for drug screening emzyme inhibitors using genetically engineered animal models; for anticancer agents |
| 10/14/2004 | US20040203104 for drug screening enzyme inhibitors; genetic engineering; comprising subjecting the sample to a polymerase chain reaction, a northern hybridization assay or an in situ hybridization assay |
| 10/14/2004 | US20040203102 Antiplasmin cleaving enzyme |
| 10/14/2004 | US20040203098 Compounds and methods for modulating activation of NF-kappaB |
| 10/14/2004 | US20040203097 Kinases and phosphatases |
| 10/14/2004 | US20040203092 UDP-N-acetylglucosamine:galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203088 Method of monitoring biofouling in membrane separation systems |
| 10/14/2004 | US20040203087 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 10/14/2004 | US20040203086 high speed; for analyzing glucose-6-phosphate dehydrogenase, total serum cholesterol, beta-lactamase activity and peroxidase activity |
| 10/14/2004 | US20040203083 immunoassay |
| 10/14/2004 | US20040203079 analyzing lipocalin-type prostaglandin D2 synthase (PGDS); immunoassay; for pain management during trauma, labor and delivery, and surgery |
| 10/14/2004 | US20040203078 Labeled complex, process for producing same and process for utilizing same |
| 10/14/2004 | US20040203076 comprises immunoglobulins (I2), outer membrane protein C (OmpC), anti-Saccharomyces cerevisiae antibodies (ASCA) |
| 10/14/2004 | US20040203064 Using expressed sequence tags to correlate gene expression profiles with stress/disease phenotypes |
| 10/14/2004 | US20040203063 Comprises nucleotide sequence coding tumor marker protein for use in diagnosis of prostate cancer |
| 10/14/2004 | US20040203061 Using primer mismatches to identify and amplify polymorphic target gene sequences; mutational analysis; multiplex detection of nucleic acid sequence differences |
| 10/14/2004 | US20040203060 Identifying modulators which decrease expression of melanoma differentiation associated factor (MDA) in tumor cells and lessens multidrug resistance in tumor cells; antitumor agents |
| 10/14/2004 | US20040203056 Chemical amplification for the synthesis of patterned arrays |
| 10/14/2004 | US20040203055 Block for filling multicompartment biochip device for use in gene expression and interaction analysis |
| 10/14/2004 | US20040203050 Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression |
| 10/14/2004 | US20040203049 Coresponding biopolymer information coded on magnetic strip with silicon chip linked biopolymers |
| 10/14/2004 | US20040203048 Monitoring nucleotide sequence methylation state via differential labeling with carbon-14 and tritium; identifying restriction fragment length polymorphisms |
| 10/14/2004 | US20040203045 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
| 10/14/2004 | US20040203043 Using multipathway high throughput assays to determine most effective combinations of modulator for treatment of acne, dandruff, cavities, skin disorders and infections |
| 10/14/2004 | US20040203041 Using probablistic analysis of nucleic acid sequences to determine nucleotide sequence, parameters of exons, sequence insertion/deletion events and open reading frames; bioinformatics and genetic/physical mapping of genes |
| 10/14/2004 | US20040203040 can be effectively and stably immobilized on the substrate, containing an organic solvent, and a substance for solubilizing the probe in the organic solvent; solid phase synthesis |
| 10/14/2004 | US20040203038 Process for preparing novel cyanine dye labeling reagents |
| 10/14/2004 | US20040203037 kits for diagnosing, monitoring, or predicting the conditions of pre-eclaimpsia, fetal chromosomal aneuploidy, and pre-term labor in a pregnant woman, as well as for detecting pregnancy |
| 10/14/2004 | US20040203035 kit for detection and characterization of mutations associated with non-syndromic hearing impairment |
| 10/14/2004 | US20040203034 Optimization of cancer treatment with irinotecan |
| 10/14/2004 | US20040203032 Pre-selection and isolation of single nucleotide polymorphisms |